NANOTIS
Nanotis is a company which Solve various problems in infectious disease tests such as influenza.
NANOTIS
Industry:
Biotechnology Health Care Health Diagnostics Nursing And Residential Care
Founded:
2016-06-01
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.nanotis.net
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
125 M JPY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Font Awesome Euro Yoast WordPress SEO Plugin
Similar Organizations
Lucira Health
Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Mirvie
Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
Current Employees Featured
Founder
Investors List
Nissha Co., Ltd.
Nissha Co., Ltd. investment in Seed Round - Nanotis
Hamamatsu Photonics
Hamamatsu Photonics investment in Seed Round - Nanotis
Taisho Pharmaceutical Holdings
Taisho Pharmaceutical Holdings investment in Seed Round - Nanotis
Shizuoka Capital Wealth Management
Shizuoka Capital Wealth Management investment in Corporate Round - Nanotis
Hamamatsu Photonics
Hamamatsu Photonics investment in Corporate Round - Nanotis
Official Site Inspections
http://www.nanotis.net
- Host name: www14.gmoserver.jp
- IP address: 157.7.231.192
- Location: Tokyo Japan
- Latitude: 35.6882
- Longitude: 139.7532
- Timezone: Asia/Tokyo
- Postal: 102-0082
More informations about "Nanotis"
Nanotis | Saliva-Based Digital Infection Testing Technology
次世代の感染症デジタル検査技術「nanotis法」 新型コロナ、インフルエンザをはじめ幅広いウイルスへ適応可能See details»
CONCEPT - Nanotis
Nanotis provides scalable screening tests to a wide range of entities, including healthcare institutions, individuals, businesses, care facilities, educational institutions, event venues, and more, ushering in a new era of value.See details»
Nanotis | Saliva-Based Digital Infection Testing …
The NANOTIS Method, a next-generation digital inspection technology for infectious diseases. Available for a wide range of viruses, including COVID-19 and influenza virusesSee details»
Nanotis Corporation - LinkedIn
We are thrilled to announce that we have successfully raised 900 million yen (≒6M USD) in a Seed2 round from Eiken Chemical Co., Ltd., a leading company in clinical diagnostics! Now that we have...See details»
ナノティス株式会社 | InfoBase - infbs.net
「NANOTIS法（Nucleic Acid Navigated Optically Traceable Immuno‐Sensing）」という唾液による感染症デジタル検査技術を開発しています。 「NANOTIS法」は、インフルエンザや新型 …See details»
Nanotis - Crunchbase Company Profile & Funding
Nanotis is a company which Solve various problems in infectious disease tests such as influenza. A digital infection testing technology that uses nucleic acid navigated optically traceable immuno-sensing to detect and concentrate virus …See details»
Nanotis Company Profile 2024: Valuation, Funding & Investors
Developer of medical diagnosis devices intended to provide accurate information to all people struggling with illness. The company develops early diagnosis devices that are valuable for …See details»
Lisa Sakashita, CEO, Nanotis | Hamamatsu Photonics
Nanotis Corporation is a 2016 spin-out from the University of Tokyo that has been researching and developing next-generation testing devices for influenza and other infectious diseases. …See details»
News Release - eiken.co.jp
Equity investment in Nanotis Corporation (Headquarters: Shibuya-ku, Tokyo; CEO, Founder: Lisa Sakashita), a startup collaborating with the University of Tokyo, developing next-generation …See details»
TEAM - Nanotis
In 2021, he became the development group leader and continued to oversee new product development of clinical laboratory analyzers. He resonated with Nanotis' vision of achieving highly-sensitive and rapid testing, and in 2022, he joined as …See details»
東京大学発ベンチャーのナノティス、迅速検査デバイ …
May 20, 2020 · インフルエンザ等感染症迅速検査デバイスの研究開発を行う東京大学発ベンチャーのナノティス株式会社（本社：東京都渋谷区、代表取締役CEO, Founder：坂下理紗、以下、ナノティス）は、大正製薬株式会社（本 …See details»
ナノティス - STARTUP DB｜スタートアップデータベース
将来は医療機関での使用をはじめオンライン診療での早期検査実現、空港での水際対策の実施、世界規模での疫学調査へデータ提供といった多様な状況下へソリューションを提供する、次 …See details»
Nanotis Company Profile - Office Locations, Competitors ... - Craft
Nanotis (ナノティス) is a company developing diagnosis devices. It utilizes nanotechnology to provide a series of microchips for the testing of SARS, MERS, Zika fever, dengue fever, and …See details»
東京大学発ベンチャーのナノティス、次世代の感染症検査デバイ …
Apr 15, 2021 · ナノティスで開発中の生体粒子検出技術はインフルエンザや新型コロナウィルスをはじめとする呼吸器感染症全般への適応が可能で、唾液で迅速、誰でもできる簡便な操作 …See details»
ナノティス株式会社の会社情報と資金調達 | NIKKEI COMPASS
Aug 9, 2023 · ナノティス株式会社は、呼吸器感染症の検査デバイスを開発する企業。 同社が開発する検査デバイスは、唾液から呼吸器感染症の検査ができ、PCR等の遺伝子検査よりも安 …See details»
Nanotis, the UTokyo-linked start-up, raises ¥45M from
Oct 15, 2018 · Nanotis, which was established in June 2016, is a start-up company related to the University of Tokyo. Our corporate mission is to “Provide all people who combat diseases with …See details»
臨床検査薬のパイオニアである栄研化学が唾液による感染症デジ …
Oct 31, 2024 · ナノティスは2016 年創業の東京大学発ベンチャーで、「感染症に怯えず暮らせる世界を創る」というミッションのもと、正確・迅速・簡単・安価なデジタル検査機器の研究 …See details»
東京大学発ベンチャーのナノティス、次世代の感染症検査 デバイ …
Apr 14, 2021 · 次世代の感染症迅速検査デバイスの研究開発を行う東京大学発ベンチャー、ナノティス株式会社（本社：東京都渋谷区、代表取締役CEO, Founder：坂下理紗、以下、ナノ …See details»
ナノティス株式会社 - スピーダ スタートアップ情報 ...
Jul 4, 2022 · 唾液による感染症デジタル検査技術「NANOTIS法（Nucleic Acid Navigated Optically Traceable Immuno‐Sensing）」を開発。 「NANOTIS法」は、ウイルス核タンパク …See details»
NEWS - Nanotis
お知らせ 2024年12月5日 GHIT R&D Forum 2024に出展します 。詳細はこちら お知らせ 2024年10月31日 栄研化学株式会社からSeed2ラウンドを実施しました 。詳細はこちら お知らせ …See details»